
Pipeline Reports
The HIV, HCV and TB Diagnostics 2024 Pipelines are online and available for download now.
March 20, 2025
SURVEY OPEN: Scoping Community Interventions to Support New TB Vaccine Introduction: From Grassroots Partnerships to Global Policymaking
TAG, with support from Wellcome, is conducting a scoping exercise of community partners and interventions to support new TB vaccine readiness.
March 19, 2025
TAG Launches TB Vaccines Pipeline Report
Publication
TAG is pleased to share the latest edition of our Tuberculosis Vaccines Pipeline Report, written by TB project co-director Mike Frick. The report provides the latest information on 17 vaccine candidates under clinical development and summarizes ongoing, planned, and recently completed clinical trials in two comprehensive tables.
March 18, 2025
TAG Defends Continuing Vital TB and HIV Research in South Africa
Statement / Press
Treatment Action Group (TAG) opposes in the strongest possible terms the termination of National Institutes of Health (NIH) research awards and contracts to South Africa, feared following reporting by Science.
March 17, 2025
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).
March 7, 2025
Treatment Action Group Opposes the Nomination of Dr. Jay Bhattacharya for Director of the U.S. National Institutes of Health
Statement / Press
The nomination of Dr. Jay Bhattacharya for Director of the United States National Institutes of Health (NIH) continues the pattern of un- and under-qualified nominees put forward by the current administration.
February 27, 2025
HIV Cure Research Information Sheet
Publication
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.
February 26, 2025
ANEA and TAG Stand in Solidarity with Demonstrators Fighting to Save PEPFAR
Statement / Press
The ACT NOW: END AIDS Coalition (ANEA) and Treatment Action Group (TAG) are proud to stand in solidarity with activists demonstrating today at the U.S. Capitol demanding that the U.S. government restore full funding to the President’s Emergency Plan for AIDS Relief (PEPFAR)
February 18, 2025
TAG Fiercely Condemns the New Administration’s War on Science
Statement / Press
Treatment Action Group (TAG) is disgusted and appalled by the new presidential administration’s flagrant attack on science.
February 7, 2025
2025 Pre-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2025 Pre-CROI Community HIV Cure Research Workshop will take place on Saturday, March 8 in San Francisco.
February 6, 2025
TAG Joins Allies at State Department to Demand Full Restoration of US Support for Global AIDS Programs
Statement / Press
Treatment Action Group (TAG) fiercely condemns the new presidential administration’s deadly and hateful attack on people living with HIV and their communities at home and around the world.
February 5, 2025
TAG Executive Director Warns: “They Don’t Care If We Live or Die”
This title of this page is one of the quotes by Mark Harrington from his recent appearance on +Life Media with TAG board member Karl Schmid. We rate this video absolutely must watch!
February 4, 2025
Letter Urging Congress to Reject All Proposals to Cut Medicaid
Letter / Comment
TAG was proud to sign on to this 2/3/25 letter created by HIV Health Care Access Working Group (HHCAWG) of the Federal AIDS Policy Partnership (FAPP). It’s addressed to Congressional leaders and urges Congress to adamantly reject all proposals to enact cuts to Medicaid, a vital source of HIV prevention, treatment, and care.
January 29, 2025
Community Surveys Show Enthusiasm for Long-Acting HCV Cure Research
Statement / Press
People living with or at risk of hepatitis C Virus (HCV), health care providers, and policymakers in low- and middle-income countries (LMICs) showed significant interest in a potential long-acting HCV cure, recent surveys have found.
January 22, 2025
TAG Rejects the Transphobia and Science Denialism of the New Presidential Administration
Statement / Press
The new U.S. presidential administration has issued several executive orders, which use pseudo-scientific claims to deny the existence of transgender and non-binary people.
January 21, 2025
TAG Condemns Planned U.S. Withdrawal from WHO
Statement / Press
Treatment Action Group (TAG) is appalled by President Donald Trump’s executive order Monday signaling the United States will be withdrawing from the World Health Organization (WHO).
January 21, 2025
TAG’s Submission to the Office of the High Commissioner for Human Rights (OHCHR)
Letter / Comment
TAG submitted this this input for the Office of the High Commissioner on Human Rights (OHCHR), in response to its request for “Inputs for the comprehensive report, incl. new developments, in ensuring access to medicines, vaccines and other health products.”
December 13, 2024
2024 Report on TB Research Funding Trends
TB R&D Report
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
December 13, 2024
TB R&D Funding: Billions Short and Reliant on a Few Major Donors, New Report Finds
Statement / Press
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
December 9, 2024
Cheat Sheets for Tuberculosis Activists
Publication
TAG’s Cheat Sheets for Tuberculosis Activists are designed to help advocates navigate the range of tools in use and in the research pipeline.
November 26, 2024
Community Trainings on Drug-Resistant TB
Webinar / Presentation
To help advocates stay up to date, Treatment Action Group (TAG) organized a series of virtual trainings on the diagnosis, treatment, care and support of people with drug-resistant TB, designed for community and civil society organizations.
November 26, 2024
TAGline November 2024
TAGline
This year’s edition of TAGline takes stock of the state of the HIV, TB, and HCV pandemics worldwide, and advances bold visions for what a future without them must look like.
November 25, 2024
1/4/6×24 Campaign Concerned Prices Hinder Uptake of Important Updated World Health Organization Drug-Resistant TB Treatment Recommendations
Statement / Press
The 1/4/6×24 Campaign warns that regimens to treat drug-resistant TB recently recommended by World Health Organization (WHO) and important diagnostic tools will remain out of reach due to high prices.
November 20, 2024
2024 TAG Update
Publication
As we approach the end of 2024, we want to share with you some of the remarkable progress we’ve made together, and you’ll see some of our work in the 2024 TAG Update.
November 13, 2024
Finally, Children of All Ages Can Benefit from 3HP to Prevent TB!
Statement / Press
The Community Research Advisors Group (CRAG) celebrates both the findings and the methodology of Study 35, a phase I/II clinical trial of the tuberculosis (TB) preventive treatment regimen known as 3HP in children.
November 11, 2024
TAG Statement on the Global Fund and Other Funding Sources to Fight TB, HIV, and Other Pandemics
Statement / Press
In advance of the 52nd Meeting of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund) and the 2024 Union World Conference on Lung Health, Treatment Action Group (TAG) releases this statement in response to ongoing conversations about the Global Fund’s program allocations for HIV, tuberculosis (TB), and malaria.